Related references
Note: Only part of the references are listed.Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
Jonathan J. Keats et al.
CANCER CELL (2007)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia
Petra S. Bachmann et al.
CANCER RESEARCH (2007)
Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells
Beatriz Sanchez-Vega et al.
MOLECULAR CANCER THERAPEUTICS (2006)
MLN120B, a novel IκB kinase β inhibitor, blocks multiple myeloma cell growth in vitro and in vivo
Teru Hideshima et al.
CLINICAL CANCER RESEARCH (2006)
Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor
PS Bachmann et al.
BLOOD (2005)
Identification of target genes involved in the antiproliferative effect of glucocorticoids reveals a role for nuclear factor-κB repression
LG Bladh et al.
MOLECULAR ENDOCRINOLOGY (2005)
Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-κB and activator protein-1 repression
LG Bladh et al.
MOLECULAR PHARMACOLOGY (2005)
Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis
AC Bharti et al.
BLOOD (2004)
Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA
MT Abrams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells
P Gomez-Bougie et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Characterization of the MM.1 human multiple myeloma (MM) cell lines: A model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells
S Greenstein et al.
EXPERIMENTAL HEMATOLOGY (2003)
Biologic sequelae of nuclear factor-κB blockade in multiple myeloma:: therapeutic applications
N Mitsiades et al.
BLOOD (2002)
NF-κB as a therapeutic target in multiple myeloma
T Hideshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays
D Chauhan et al.
ONCOGENE (2002)
Gene structure, alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim
P Bouillet et al.
MAMMALIAN GENOME (2001)
Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors
T Shinjyo et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-κB and induction of apoptosis
YX Tao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
